HK Stock MarketDetailed Quotes

01065 TIANJIN CAPITAL

Watchlist
  • 3.160
  • -0.030-0.94%
Trading Dec 3 10:24 CST
4.96BMarket Cap5.08P/E (TTM)

TIANJIN CAPITAL Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Turnover
3.91%3.39B
5.18%2.22B
10.61%1.08B
3.16%4.67B
0.86%3.26B
-0.95%2.11B
-8.86%976.64M
-0.30%4.52B
-0.94%3.23B
11.84%2.13B
Operating income
3.91%3.39B
5.18%2.22B
10.61%1.08B
3.16%4.67B
0.86%3.26B
-0.95%2.11B
-8.86%976.64M
-0.30%4.52B
-0.94%3.23B
11.84%2.13B
Operating expenses
-1.60%-2.13B
-3.95%-1.38B
-7.23%-646.29M
4.74%-2.84B
0.67%-2.09B
6.55%-1.32B
15.45%-602.73M
6.34%-2.99B
7.65%-2.11B
-11.98%-1.42B
Gross profit
8.05%1.26B
7.24%842.99M
16.07%433.99M
18.52%1.82B
3.74%1.17B
10.15%786.07M
4.25%373.9M
14.02%1.54B
14.65%1.13B
11.54%713.67M
Selling expenses
2.17%-7.79M
54.27%-5.11M
33.24%-2.96M
21.13%-11.47M
56.34%-7.96M
12.06%-11.18M
36.78%-4.43M
-22.90%-14.55M
19.55%-18.23M
-0.31%-12.72M
Administrative expenses
1.66%-145.09M
2.12%-94.7M
2.82%-46.07M
-8.69%-240.13M
-7.92%-147.54M
-7.13%-96.76M
-8.63%-47.4M
1.73%-220.94M
-8.06%-136.71M
-9.01%-90.31M
Research and development expenses
-30.08%-30.86M
-79.94%-20.83M
-45.95%-8.34M
-21.87%-53.06M
-78.02%-23.73M
-76.72%-11.58M
-140.72%-5.72M
-137.33%-43.54M
-92.31%-13.33M
-276.74%-6.55M
Profit from asset sales
----
----
----
100.94%24K
----
----
----
-11,527.27%-2.56M
--49K
----
Impairment and provision
35.14%-1.22M
35.14%-1.22M
--0
-52.89%-245.34M
58.72%-1.88M
77.46%-1.88M
94.90%-259K
-8.66%-160.46M
-119.12%-4.55M
-301.30%-8.33M
-Other impairment is provision
35.14%-1.22M
35.14%-1.22M
--0
-52.89%-245.34M
58.72%-1.88M
77.46%-1.88M
94.90%-259K
-8.66%-160.46M
-119.12%-4.55M
-301.30%-8.33M
Special items of operating profit
0.07%64.99M
8.80%44.01M
11.87%19.84M
-9.13%92.57M
-8.55%64.94M
-12.34%40.45M
-23.47%17.74M
-10.50%101.87M
-9.88%71.02M
5.46%46.14M
Operating profit
8.68%1.11B
8.83%742.73M
19.96%392.57M
14.38%1.32B
2.71%1.02B
10.09%682.48M
3.59%327.26M
13.49%1.15B
13.80%996.67M
8.92%619.95M
Financing cost
-43.46%-258.22M
-48.98%-177.27M
-55.75%-90.82M
-18.12%-213.14M
-3.34%-179.99M
-6.76%-118.99M
-5.72%-58.31M
-54.64%-180.45M
2.27%-174.18M
31.07%-111.46M
Special items of earning before tax
51.00%4.52M
47.71%4.73M
-95.84%121K
635.44%3.55M
266.89%2.99M
549.86%3.2M
504.17%2.91M
30.21%-663K
34.53%-1.79M
23.69%-712K
Earning before tax
1.44%858.87M
0.62%570.18M
11.04%301.86M
14.12%1.11B
3.17%846.69M
11.60%566.69M
4.55%271.85M
8.17%969.3M
18.11%820.7M
24.90%507.78M
Tax
17.52%-126.22M
1.92%-109.51M
12.40%-52.29M
-29.40%-202.77M
5.20%-153.03M
-15.73%-111.65M
-2.14%-59.69M
11.50%-156.69M
-44.04%-161.42M
-38.21%-96.48M
After-tax profit from continuing operations
5.62%732.65M
1.24%460.68M
17.63%249.57M
11.18%903.44M
5.21%693.66M
10.63%455.05M
5.25%212.16M
13.02%812.61M
13.13%659.28M
22.14%411.31M
After-tax profit from non-continuing business
--0
----
----
----
--0
----
----
----
--0
----
Earning after tax
5.62%732.65M
1.24%460.68M
17.63%249.57M
11.18%903.44M
5.21%693.66M
10.63%455.05M
5.25%212.16M
13.02%812.61M
13.13%659.28M
22.14%411.31M
Minority profit
69.88%55.09M
125.30%38.75M
-147.88%-2.02M
-37.68%38.24M
23.03%32.43M
15.10%17.2M
-31.80%4.22M
137.60%61.35M
-30.80%26.36M
-53.68%14.94M
Profit attributable to shareholders
2.47%677.56M
-3.64%421.93M
21.00%251.6M
15.17%865.21M
4.47%661.23M
10.47%437.85M
6.42%207.94M
8.38%751.25M
16.20%632.92M
30.17%396.36M
Basic earnings per share
2.38%0.43
-3.57%0.27
21.21%0.16
7.84%0.55
-4.55%0.42
0.00%0.28
-3.65%0.132
4.08%0.51
15.79%0.44
33.33%0.28
Diluted earnings per share
2.38%0.43
-3.57%0.27
21.21%0.16
7.84%0.55
-4.55%0.42
0.00%0.28
-3.65%0.132
4.08%0.51
15.79%0.44
33.33%0.28
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
Auditor
--
--
--
PricewaterhouseCoopers
--
--
--
PricewaterhouseCoopers
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Turnover 3.91%3.39B5.18%2.22B10.61%1.08B3.16%4.67B0.86%3.26B-0.95%2.11B-8.86%976.64M-0.30%4.52B-0.94%3.23B11.84%2.13B
Operating income 3.91%3.39B5.18%2.22B10.61%1.08B3.16%4.67B0.86%3.26B-0.95%2.11B-8.86%976.64M-0.30%4.52B-0.94%3.23B11.84%2.13B
Operating expenses -1.60%-2.13B-3.95%-1.38B-7.23%-646.29M4.74%-2.84B0.67%-2.09B6.55%-1.32B15.45%-602.73M6.34%-2.99B7.65%-2.11B-11.98%-1.42B
Gross profit 8.05%1.26B7.24%842.99M16.07%433.99M18.52%1.82B3.74%1.17B10.15%786.07M4.25%373.9M14.02%1.54B14.65%1.13B11.54%713.67M
Selling expenses 2.17%-7.79M54.27%-5.11M33.24%-2.96M21.13%-11.47M56.34%-7.96M12.06%-11.18M36.78%-4.43M-22.90%-14.55M19.55%-18.23M-0.31%-12.72M
Administrative expenses 1.66%-145.09M2.12%-94.7M2.82%-46.07M-8.69%-240.13M-7.92%-147.54M-7.13%-96.76M-8.63%-47.4M1.73%-220.94M-8.06%-136.71M-9.01%-90.31M
Research and development expenses -30.08%-30.86M-79.94%-20.83M-45.95%-8.34M-21.87%-53.06M-78.02%-23.73M-76.72%-11.58M-140.72%-5.72M-137.33%-43.54M-92.31%-13.33M-276.74%-6.55M
Profit from asset sales ------------100.94%24K-------------11,527.27%-2.56M--49K----
Impairment and provision 35.14%-1.22M35.14%-1.22M--0-52.89%-245.34M58.72%-1.88M77.46%-1.88M94.90%-259K-8.66%-160.46M-119.12%-4.55M-301.30%-8.33M
-Other impairment is provision 35.14%-1.22M35.14%-1.22M--0-52.89%-245.34M58.72%-1.88M77.46%-1.88M94.90%-259K-8.66%-160.46M-119.12%-4.55M-301.30%-8.33M
Special items of operating profit 0.07%64.99M8.80%44.01M11.87%19.84M-9.13%92.57M-8.55%64.94M-12.34%40.45M-23.47%17.74M-10.50%101.87M-9.88%71.02M5.46%46.14M
Operating profit 8.68%1.11B8.83%742.73M19.96%392.57M14.38%1.32B2.71%1.02B10.09%682.48M3.59%327.26M13.49%1.15B13.80%996.67M8.92%619.95M
Financing cost -43.46%-258.22M-48.98%-177.27M-55.75%-90.82M-18.12%-213.14M-3.34%-179.99M-6.76%-118.99M-5.72%-58.31M-54.64%-180.45M2.27%-174.18M31.07%-111.46M
Special items of earning before tax 51.00%4.52M47.71%4.73M-95.84%121K635.44%3.55M266.89%2.99M549.86%3.2M504.17%2.91M30.21%-663K34.53%-1.79M23.69%-712K
Earning before tax 1.44%858.87M0.62%570.18M11.04%301.86M14.12%1.11B3.17%846.69M11.60%566.69M4.55%271.85M8.17%969.3M18.11%820.7M24.90%507.78M
Tax 17.52%-126.22M1.92%-109.51M12.40%-52.29M-29.40%-202.77M5.20%-153.03M-15.73%-111.65M-2.14%-59.69M11.50%-156.69M-44.04%-161.42M-38.21%-96.48M
After-tax profit from continuing operations 5.62%732.65M1.24%460.68M17.63%249.57M11.18%903.44M5.21%693.66M10.63%455.05M5.25%212.16M13.02%812.61M13.13%659.28M22.14%411.31M
After-tax profit from non-continuing business --0--------------0--------------0----
Earning after tax 5.62%732.65M1.24%460.68M17.63%249.57M11.18%903.44M5.21%693.66M10.63%455.05M5.25%212.16M13.02%812.61M13.13%659.28M22.14%411.31M
Minority profit 69.88%55.09M125.30%38.75M-147.88%-2.02M-37.68%38.24M23.03%32.43M15.10%17.2M-31.80%4.22M137.60%61.35M-30.80%26.36M-53.68%14.94M
Profit attributable to shareholders 2.47%677.56M-3.64%421.93M21.00%251.6M15.17%865.21M4.47%661.23M10.47%437.85M6.42%207.94M8.38%751.25M16.20%632.92M30.17%396.36M
Basic earnings per share 2.38%0.43-3.57%0.2721.21%0.167.84%0.55-4.55%0.420.00%0.28-3.65%0.1324.08%0.5115.79%0.4433.33%0.28
Diluted earnings per share 2.38%0.43-3.57%0.2721.21%0.167.84%0.55-4.55%0.420.00%0.28-3.65%0.1324.08%0.5115.79%0.4433.33%0.28
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified Opinion------Unqualified Opinion----
Auditor ------PricewaterhouseCoopers------PricewaterhouseCoopers----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data